Cargando…

Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study

BACKGROUND: Surfactant protein D (SP-D), an innate immune molecule, plays an important protective role during airway inflammation. Deficiency of this molecule induces emphysematous changes in murine lungs, but its significance in human COPD remains unclear. METHODS: We collected bronchoalveolar lava...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sims, Michael W, Tal-Singer, Ruth M, Kierstein, Sonja, Musani, Ali I, Beers, Michael F, Panettieri, Reynold A, Haczku, Angela
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2249580/ https://www.ncbi.nlm.nih.gov/pubmed/18226251 http://dx.doi.org/10.1186/1465-9921-9-13

Ejemplares similares

Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D
por: Kierstein, S, et al.
Publicado: (2006)

Attenuated allergic airway hyperresponsiveness in C57BL/6 mice is associated with enhanced surfactant protein (SP)-D production following allergic sensitization
por: Atochina, Elena N, et al.
Publicado: (2003)

Surfactant Protein-A inhibits Aspergillus fumigatus-induced allergic T-cell responses
por: Scanlon, Seth Thomas, et al.
Publicado: (2005)

Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease
por: Sims, Michael W, et al.
Publicado: (2011)

O03 - Expression of pulmonary surfactant protein D (SP-D) and interleukin 13 in the serum of atopic and non-atopic severe pediatric asthmatics: effects of glucocorticoid and sodium cromoglycate treatment
por: Gemou-Engesaeth, Vasiliki, et al.
Publicado: (2014)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Asthma in the elderly: a study of the role of vitamin D
por: Columbo, Michele, et al.
Publicado: (2014)

Coccidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)-A and SP-D
por: Awasthi, Shanjana, et al.
Publicado: (2004)

S-Nitrosylation of Surfactant Protein-D Controls Inflammatory Function
por: Guo, Chang-Jiang, et al.
Publicado: (2008)

Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced
por: Heidinger, Kathrin, et al.
Publicado: (2005)

Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD
por: Winkler, Carla, et al.
Publicado: (2011)

Pulmonary Surfactant and Drug Delivery: An Interface-Assisted Carrier to Deliver Surfactant Protein SP-D Into the Airways
por: García-Mouton, Cristina, et al.
Publicado: (2021)

Common Genetic Variants of Surfactant Protein-D (SP-D) Are Associated with Type 2 Diabetes
por: Pueyo, Neus, et al.
Publicado: (2013)

Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection
por: Salvioni, Lucia, et al.
Publicado: (2022)

An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity
por: Nayak, Annapurna, et al.
Publicado: (2012)

Surfactant proteins, SP-A and SP-D, in respiratory fungal infections: their role in the inflammatory response
por: Carreto-Binaghi, Laura Elena, et al.
Publicado: (2016)

Editorial: Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules
por: Kishore, Uday, et al.
Publicado: (2020)

Serum Surfactant Protein D: Biomarker of Chronic Obstructive Pulmonary Disease
por: Ju, Chun-Rong, et al.
Publicado: (2012)

Surfactant Proteins SP-A and SP-D Modulate Uterine Contractile Events in ULTR Myometrial Cell Line
por: Sotiriadis, Georgios, et al.
Publicado: (2015)

The dendritic cell niche in chronic obstructive pulmonary disease
por: Haczku, Angela
Publicado: (2012)

Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease
por: Moré, Jayaji M, et al.
Publicado: (2010)

Correlation of Surfactant Protein-D (SP-D) Serum Levels with ARDS Severity and Mortality in Covid-19 Patients in Indonesia
por: Agustama, Alexander, et al.
Publicado: (2022)

“SP-G”, a Putative New Surfactant Protein – Tissue Localization and 3D Structure
por: Rausch, Felix, et al.
Publicado: (2012)

Glycosylation of H4 influenza strains with pandemic potential and susceptibilities to lung surfactant SP-D
por: Parsons, Lisa M., et al.
Publicado: (2023)

Serum Surfactant Protein D during Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Shakoori, Tania Ahmed, et al.
Publicado: (2009)

Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease
por: Ozyurek, Berna Akinci, et al.
Publicado: (2013)

Diagnosis of Chronic Obstructive Pulmonary Disease and Regulatory Mechanism of miR-149-3p on Alveolar Inflammatory Factors and Expression of Surfactant Proteins A (SP-A) and D (SP-D) on Lung Surface Mediated by Wnt Pathway
por: Zhang, Xiuli, et al.
Publicado: (2022)

Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease
por: Kunisaki, Ken M, et al.
Publicado: (2011)

Surfactant protein-D (SP-D) gene polymorphisms and serum level as predictors of susceptibility and prognosis of acute kidney injury in the Chinese population
por: Liu, Jiao, et al.
Publicado: (2017)

The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease
por: Zien Alaabden, Alaa, et al.
Publicado: (2016)

Lung surfactant as a biophysical assay for inhalation toxicology
por: Liu, James Y., et al.
Publicado: (2022)

Inhaled Surfactant in the treatment of accidental Talc Powder inhalation: a new case report
por: Matina, Federico, et al.
Publicado: (2011)

Alterations of the murine gut microbiome in allergic airway disease are independent of surfactant protein D
por: Barfod, Kenneth K., et al.
Publicado: (2017)

Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial
por: Panettieri Jr, Reynold A, et al.
Publicado: (2022)

Anaphylatoxin C3a receptors in asthma
por: Ali, Hydar, et al.
Publicado: (2005)

Reviewer acknowledgement 2012
por: Lötvall, Jan, et al.
Publicado: (2013)

Reviewer acknowledgement 2013
por: Lötvall, Jan, et al.
Publicado: (2014)

Reviewer acknowledgement 2015
por: Lötvall, Jan, et al.
Publicado: (2016)

Reviewer acknowledgement 2014
por: Lötvall, Jan, et al.
Publicado: (2015)

Thank you and farewell after 15 years editing respiratory research
por: Lotvall, Jan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sb3ihjnat3efgilb2t3rapmnb0